STC2 and cancer: As shown in Figure S1, STC2 is overexpressed across a range of cancers, including bladder, colon, esophagus, liver, lung, ovary, pancreas, prostate, rectum, renal cell carcinoma, skin, testis, thyroid, and uterus.